-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Afatinib Dimaleate in Low-Grade Glioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Afatinib Dimaleate in Low-Grade Glioma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Afatinib Dimaleate in Low-Grade Glioma Drug Details: Afatinib dimaleate (Giotrif, Gilotrif,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – STA-363 in Chronic Low Back Pain (CLBP)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - STA-363 in Chronic Low Back Pain (CLBP) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. STA-363 in Chronic Low Back Pain (CLBP) Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Acetaminophen + Naltrexone) in Chronic Low Back Pain (CLBP)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Acetaminophen + Naltrexone) in Chronic Low Back Pain (CLBP) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Acetaminophen + Naltrexone) in Chronic Low...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – LY-3857210 in Chronic Low Back Pain (CLBP)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LY-3857210 in Chronic Low Back Pain (CLBP) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LY-3857210 in Chronic Low Back Pain (CLBP) Drug Details:...
-
Product Insights
Low Carbon Birch Solar PV Plant, UK
Low Carbon Birch Solar PV Plant is proposed to be built in England, United Kingdom. The project is at the permitting stage. Empower your strategies with our Low Carbon Birch Solar PV Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered...
-
Product Insights
Low-Grade Glioma – Drugs In Development, 2023
Global Markets Direct’s, ‘Low-Grade Glioma - Drugs In Development, 2023’, provides an overview of the Low-Grade Glioma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Low-Grade Glioma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Low Density Lipoprotein Receptor Related Protein – Drugs In Development, 2023
Global Markets Direct’s Low Density Lipoprotein Receptor Related Protein provides in depth analysis on Low Density Lipoprotein Receptor Related Protein targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved...
-
Product Insights
Fc Fragment Of IgG Low Affinity III Receptor – Drugs In Development, 2023
Global Markets Direct’s Fc Fragment Of IgG Low Affinity III Receptor provides in depth analysis on Fc Fragment Of IgG Low Affinity III Receptor targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview...
-
Product Insights
Low Density Lipoprotein Receptor Related Protein 6 – Drugs In Development, 2023
Global Markets Direct’s Low Density Lipoprotein Receptor Related Protein 6 provides in depth analysis on Low Density Lipoprotein Receptor Related Protein 6 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Low Density Lipoprotein Receptor Related Protein 5 – Drugs In Development, 2023
Global Markets Direct’s Low Density Lipoprotein Receptor Related Protein 5 provides in depth analysis on Low Density Lipoprotein Receptor Related Protein 5 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...